AstraZeneca's first-quarter Covid-19 vaccine revenue hits $275 million

AstraZeneca said its Covid-19 vaccine contributed $275 million in sales and shaved off three cents per share from its first-quarter earnings.

https://ift.tt/3gRLWHY

Post a Comment

0 Comments